Table 2.

Comparative analysis of clinical features of patients between group I and group II.

	Group I (n = 15)	Group II (n = 17)	p
Age, median years (range)	29 (21–40)	30 (18–43)	0.127
Gender, female:male	7:8	7:10	0.755
HBsAg titer, median IU/mL (range)	122.47 (72.01–718.63)	119.37 (68.25–625.53)	0.610
HBeAg+ (%)	73.3	58.8	0.388
Serum ALT level, median IU/L (range)	115 (94–319)	147 (92–325)	0.692
Serum HBV DNA level, median (log 10 copies/mL)	6.71 (4.37–9.50)	5.57 (4.42–8.71)	0.234

ALT, alanine aminotransferase.